400 related articles for article (PubMed ID: 12112088)
21. Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease.
Ewers M; Zhong Z; Bürger K; Wallin A; Blennow K; Teipel SJ; Shen Y; Hampel H
Brain; 2008 May; 131(Pt 5):1252-8. PubMed ID: 18334538
[TBL] [Abstract][Full Text] [Related]
22. Autophagic vacuoles are enriched in amyloid precursor protein-secretase activities: implications for beta-amyloid peptide over-production and localization in Alzheimer's disease.
Yu WH; Kumar A; Peterhoff C; Shapiro Kulnane L; Uchiyama Y; Lamb BT; Cuervo AM; Nixon RA
Int J Biochem Cell Biol; 2004 Dec; 36(12):2531-40. PubMed ID: 15325590
[TBL] [Abstract][Full Text] [Related]
23. Morphine via nitric oxide modulates beta-amyloid metabolism: a novel protective mechanism for Alzheimer's disease.
Pak T; Cadet P; Mantione KJ; Stefano GB
Med Sci Monit; 2005 Oct; 11(10):BR357-66. PubMed ID: 16192893
[TBL] [Abstract][Full Text] [Related]
24. In vitro gamma-secretase cleavage of the Alzheimer's amyloid precursor protein correlates to a subset of presenilin complexes and is inhibited by zinc.
Hoke DE; Tan JL; Ilaya NT; Culvenor JG; Smith SJ; White AR; Masters CL; Evin GM
FEBS J; 2005 Nov; 272(21):5544-57. PubMed ID: 16262694
[TBL] [Abstract][Full Text] [Related]
25. Astrocytic expression of the Alzheimer's disease beta-secretase (BACE1) is stimulus-dependent.
Hartlage-Rübsamen M; Zeitschel U; Apelt J; Gärtner U; Franke H; Stahl T; Günther A; Schliebs R; Penkowa M; Bigl V; Rossner S
Glia; 2003 Jan; 41(2):169-79. PubMed ID: 12509807
[TBL] [Abstract][Full Text] [Related]
26. Aspartic proteases involved in Alzheimer's disease.
Schmidt B
Chembiochem; 2003 May; 4(5):366-78. PubMed ID: 12740808
[TBL] [Abstract][Full Text] [Related]
27. Caspase-3 cleavage of GGA3 stabilizes BACE: implications for Alzheimer's disease.
Vassar R
Neuron; 2007 Jun; 54(5):671-3. PubMed ID: 17553417
[TBL] [Abstract][Full Text] [Related]
28. Catalytic site-directed gamma-secretase complex inhibitors do not discriminate pharmacologically between Notch S3 and beta-APP cleavages.
Lewis HD; Pérez Revuelta BI; Nadin A; Neduvelil JG; Harrison T; Pollack SJ; Shearman MS
Biochemistry; 2003 Jun; 42(24):7580-6. PubMed ID: 12809514
[TBL] [Abstract][Full Text] [Related]
29. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
[TBL] [Abstract][Full Text] [Related]
30. Experimental traumatic brain injury in rats stimulates the expression, production and activity of Alzheimer's disease beta-secretase (BACE-1).
Blasko I; Beer R; Bigl M; Apelt J; Franz G; Rudzki D; Ransmayr G; Kampfl A; Schliebs R
J Neural Transm (Vienna); 2004 Apr; 111(4):523-36. PubMed ID: 15057522
[TBL] [Abstract][Full Text] [Related]
31. [Pathogenesis of Alzheimer's disease: implications from amyloid research front].
Iwatsubo T
Rinsho Shinkeigaku; 2004 Nov; 44(11):768-70. PubMed ID: 15651286
[TBL] [Abstract][Full Text] [Related]
32. APPepsilon, the epsilon-secretase-derived N-terminal product of the beta-amyloid precursor protein, behaves as a type I protein and undergoes alpha-, beta-, and gamma-secretase cleavages.
Lefranc-Jullien S; Sunyach C; Checler F
J Neurochem; 2006 May; 97(3):807-17. PubMed ID: 16524370
[TBL] [Abstract][Full Text] [Related]
33. Beta-secretase as a target for the treatment of Alzheimer's disease.
Citron M
J Neurosci Res; 2002 Nov; 70(3):373-9. PubMed ID: 12391600
[TBL] [Abstract][Full Text] [Related]
34. The regulation of beta-secretase by cholesterol and statins in Alzheimer's disease.
Sidera C; Parsons R; Austen B
J Neurol Sci; 2005 Mar; 229-230():269-73. PubMed ID: 15760650
[TBL] [Abstract][Full Text] [Related]
35. Dynamics of {beta}-amyloid reductions in brain, cerebrospinal fluid, and plasma of {beta}-amyloid precursor protein transgenic mice treated with a {gamma}-secretase inhibitor.
Barten DM; Guss VL; Corsa JA; Loo A; Hansel SB; Zheng M; Munoz B; Srinivasan K; Wang B; Robertson BJ; Polson CT; Wang J; Roberts SB; Hendrick JP; Anderson JJ; Loy JK; Denton R; Verdoorn TA; Smith DW; Felsenstein KM
J Pharmacol Exp Ther; 2005 Feb; 312(2):635-43. PubMed ID: 15452193
[TBL] [Abstract][Full Text] [Related]
36. gamma-Secretase can cleave amyloid precursor protein fragments independent of alpha- and beta-secretase pre-cutting.
Kume H; Sekijima Y; Maruyama K; Kametani F
Int J Mol Med; 2003 Jul; 12(1):57-60. PubMed ID: 12792809
[TBL] [Abstract][Full Text] [Related]
37. Platelet beta-secretase activity is increased in Alzheimer's disease.
Johnston JA; Liu WW; Coulson DT; Todd S; Murphy S; Brennan S; Foy CJ; Craig D; Irvine GB; Passmore AP
Neurobiol Aging; 2008 May; 29(5):661-8. PubMed ID: 17174011
[TBL] [Abstract][Full Text] [Related]
38. gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in?
Sisodia SS; St George-Hyslop PH
Nat Rev Neurosci; 2002 Apr; 3(4):281-90. PubMed ID: 11967558
[No Abstract] [Full Text] [Related]
39. Levels of beta-secretase BACE and alpha-secretase ADAM10 mRNAs in Alzheimer hippocampus.
Gatta LB; Albertini A; Ravid R; Finazzi D
Neuroreport; 2002 Nov; 13(16):2031-3. PubMed ID: 12438920
[TBL] [Abstract][Full Text] [Related]
40. Beta-secretase (BACE) and GSK-3 mRNA levels in Alzheimer's disease.
Preece P; Virley DJ; Costandi M; Coombes R; Moss SJ; Mudge AW; Jazin E; Cairns NJ
Brain Res Mol Brain Res; 2003 Aug; 116(1-2):155-8. PubMed ID: 12941471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]